Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Bell

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cell Reports|April 19, 2026
Non-canonical proteolytic activation of RNase L by SARS-CoV-2 3CL<sup>pro</sup> offsets inactivation of OAS1 p46 antiviral signalingPeter A Bell, Kaushal Baid, Christina Pan, et al.
Chemical Science|August 29, 2025
SpectraSage unveils specific proteolytic patterns of 20S on mono-ubiquitylated Tau proteoforms involved in neurodegenerationGabriele Antonio Zingale, Irene Pandino, Daniele Trivellato, et al.
Biotechniques|June 27, 2002
SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discoveryPeter A Bell, Surendra Chaturvedi, Craig A Gelfand, et al.
Tort Trial & Insurance Practice Law Journal|April 10, 2004
Recent developments in medicine and lawMelissa A Wojtylak, Kenneth C Bartholomew, Peter A Bell, et al.
Cell Reports|December 14, 2024
SARS-CoV-2 3CL<sup>pro</sup> (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CL<sup>pro</sup>Peter M Grin, Kaushal Baid, Hugo C R de Jesus, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2021
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiencyHenry Y Lu, Mehul Sharma, Ashish A Sharma, et al.
Cell Reports|October 21, 2021
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL<sup>pro</sup> substrate degradomeIsabel Pablos, Yoan Machado, Hugo C Ramos de Jesus, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cell Reports|April 19, 2026
Non-canonical proteolytic activation of RNase L by SARS-CoV-2 3CL<sup>pro</sup> offsets inactivation of OAS1 p46 antiviral signalingPeter A Bell, Kaushal Baid, Christina Pan, et al.
Chemical Science|August 29, 2025
SpectraSage unveils specific proteolytic patterns of 20S on mono-ubiquitylated Tau proteoforms involved in neurodegenerationGabriele Antonio Zingale, Irene Pandino, Daniele Trivellato, et al.
Biotechniques|June 27, 2002
SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discoveryPeter A Bell, Surendra Chaturvedi, Craig A Gelfand, et al.
Tort Trial & Insurance Practice Law Journal|April 10, 2004
Recent developments in medicine and lawMelissa A Wojtylak, Kenneth C Bartholomew, Peter A Bell, et al.
Cell Reports|December 14, 2024
SARS-CoV-2 3CL<sup>pro</sup> (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CL<sup>pro</sup>Peter M Grin, Kaushal Baid, Hugo C R de Jesus, et al.
The Journal of Allergy and Clinical Immunology|April 19, 2021
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiencyHenry Y Lu, Mehul Sharma, Ashish A Sharma, et al.
Cell Reports|October 21, 2021
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL<sup>pro</sup> substrate degradomeIsabel Pablos, Yoan Machado, Hugo C Ramos de Jesus, et al.
Pageof 3